Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Feedback loop found that could forestall liver disease

12.10.2005


Researchers at UT Southwestern Medical Center have discovered that the small intestine communicates with the liver to control the production of bile acids - a finding that has great medical implications in treating people at risk for certain types of liver disease.



"We’ve discovered a new hormone, and new hormones are always exciting," said Dr. Steven Kliewer, professor of molecular biology and pharmacology and senior author of a study available online and appearing in the October issue of Cell Metabolism.

The findings may eventually play a role in understanding and preventing liver damage that can occur in biliary cirrhosis, viral hepatitis, alcoholic liver disease and pregnancy.


The central elements in the research are the body’s bile acids - powerful and essential detergents that help digest fatty foods and fat-soluble vitamins in the small intestine.

The liver makes bile acids out of cholesterol and sends them to the gallbladder, where they’re stored until food is digested. The presence of food stimulates the gallbladder into releasing the bile acids to the small intestine, where they do their work. Finally, they’re absorbed into the bloodstream and returned to the liver.

Because they’re so powerful, bile acids can damage the body if not controlled properly.

"These bile acids are really nasty in terms of being strong detergents," said Dr. Kliewer, holder of the Nancy B. and Jake L. Hamon Distinguished Chair in Basic Cancer Research.

Scientists have previously known about a mechanism within the liver that prevents too much bile acid from being produced. Normally, a protein called CYP7A1 stimulates production of the acids. When enough bile acids are made, they trigger a series of reactions that blocks the gene for CYP7A1, and production stops.

For this study, UT Southwestern researchers looked at a protein in mice called fibroblast growth factor 15 (FGF15), which is part of a cascade of chemical reactions that also dialed down production of CYP7A1 and reduced the production of bile acids in the liver.

Surprisingly, they found that FGF15 was made in the small intestine, not in the liver, suggesting a new role for the small intestine in regulating bile acid levels.

When the researchers injected FGF15 into the bloodstream, CYP7A1 production in the liver was again shut down. Conversely, mutant mice lacking FGF15 made too much CYP7A1, and thus had abnormally high levels of bile acids.

"We can inject FGF15 in the jugular vein, and see the effects in the liver," Dr. Kliewer said.

These discoveries pointed to FGF15 acting as a hormone, which is defined as a substance that’s secreted into the bloodstream to work on distant targets.

The findings may be relevant to diseases that involve a condition called cholestatis, in which the bile ducts are blocked. When that happens bile acids accumulate in the liver and severe liver disease may follow. Cholestatis can also occur in patients who are getting all their nutrition through intravenous feeding, because the gallbladder never receives the signal from the small intestine to release bile acids.

Dr. Kliewer said perhaps giving cholestatis patients FGF19 - the human equivalent of FGF15 - may turn off the overproduction of harmful bile acids in these cases.

"So now we have a hormone that’s not going to damage the liver, that we could perhaps administer and turn off the production of bile acids, and that could alleviate one of the important causes of cholestatis," he said. "I think that’s one of the exciting implications of this."

Future research is needed to determine whether the fibroblast growth factor protein family prevents liver disease in animals, Dr. Kliewer said.

Other UT Southwestern researchers involved in the study were Drs. Takeshi Inagaki and Mihwa Choi, postdoctoral research fellows in molecular biology; Dr. Antonio Moschetta, postdoctoral research fellow in pharmacology and a research associate in the Howard Hughes Medical Institute; Li Peng, senior research assistant in molecular biology; Dr. Carolyn Cummins, postdoctoral research fellow in pharmacology and HHMI research associate; Dr. Jeffrey McDonald, assistant professor of molecular genetics; Dr. James Richardson, professor of pathology; Dr. Robert Gerard, associate professor of internal medicine and of molecular biology; Dr. Joyce Repa, assistant professor of physiology; and Dr. David Mangelsdorf, professor of pharmacology and an HHMI investigator.
Researchers from GlaxoSmithKline Research and Development also participated.

The work was supported by the National Institutes of Health, the Welch Foundation and HHMI.

Aline McKenzie | EurekAlert!
Further information:
http://www.utsouthwestern.edu

More articles from Life Sciences:

nachricht Water forms 'spine of hydration' around DNA, group finds
26.05.2017 | Cornell University

nachricht How herpesviruses win the footrace against the immune system
26.05.2017 | Helmholtz-Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>